Moneycontrol PRO
Upcoming Webinar:Join us for 'The Future Techshot' on Sept 22, 10:30am to gain insights into role of tech in streamlining businesses. Register Now!

UBS cuts India GDP growth forecast to 5.1% for FY21

The GDP growth is set to slip to a decadal low of 5 percent for FY20 as per official estimates and hopes of a revival are being pinned on the next fiscal.

March 13, 2020 / 08:54 AM IST

Swiss brokerage UBS sharply cut its 2020-21 GDP growth forecast for India to 5.1 percent on fears around the coronavirus outbreak and also weak credit growth domestically. The brokerage also cut its FY20 growth estimate marginally to 4.8 percent.

The GDP growth is set to slip to a decadal low of 5 percent for FY20 as per official estimates and hopes of a revival are being pinned on the next fiscal.

The brokerage's economist Tanvee Gupta Jain said even though there are only over 50 positive coronavirus cases in India so far, the fear and uncertainty over its impact could worsen near-term consumer sentiment and hit domestic demand.

Additionally, there will be sectoral impact on production due to shortages of inputs in electronics, pharma and automobile sectors or reduced external demand on slowing global growth, which would also have a bearing on India's growth outlook, she explained.

Apart from the coronavirus-related measures, the weak credit impulse domestically could constrain growth for the next two quarters, it said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"We now expect India's real GDP growth to remain weak at 5.1 percent YoY in FY21 (previously 5.6 percent) compared with 4.8 per cent YoY (previously 4.9 percent) in FY20," it said, adding the growth rate will continue to be under potential in FY22, when it is expected to touch 6 percent.

The brokerage said it has already taken into account the benefits of the oil prices decline while making its estimate.

Courtesy the lower growth, India will continue to be constrained fiscally even in FY21, it said, expecting the government to breach the budgeted FY21 fiscal deficit target.

There will be a 0.30 percent slippage on the crucial number during the next fiscal over the 3.5 percent aspiration, it said.
PTI
first published: Mar 13, 2020 08:29 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark